跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MET-2
首页
药物
MET-2
MET-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
US 8420645 B2
申请人: WENG LINGKAI
优先权: 2008
CN
US
12 件公开
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
US 9266890 B2
申请人: GRAY NATHANAEL S
优先权: 2010
US
6 件公开
SPINAL CORD INJURY THERAPEUTIC TARGETING FROM ACUTE PHASE TO SUBACUTE PHASE
EP 4585225 A1
申请人: UNIV KEIO
优先权: 2022
CN
EP
US
WO
4 件公开
2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for the treatment of tumours
US 8071593 B2
申请人: SCHADT OLIVER
优先权: 2007
US
4 件公开
Pyrimido-diazepinone compounds and methods of treating disorders
US 9676792 B2
申请人: DANA FARBER CANCER INST INC
优先权: 2014
US
4 件公开
METHODS OF TREATING COVID-RELATED DISORDERS
EP 4482510 A4
申请人: ATHIRA PHARMA INC
优先权: 2022
EP
US
WO
3 件公开
Bispecific Anti ErbB2 / Anti cMet Antibodies
US 2010254988 A1
申请人: BOSSENMAIER BIRGIT
优先权: 2009
CN
US
3 件公开
Glutathione-elevating compositions and uses thereof
CN 104717970 A
申请人: ONEDAY BIOTECH AND PHARMA LTD
优先权: 2013
CN
US
3 件公开
Use of protein biomolecular targets in the treatment and visualization of brain tumors
US 7060275 B2
申请人: AGY THERAPEUTICS INC
优先权: 2001
US
3 件公开
Cancer antigen peptide formulations
US 7342092 B2
申请人: INT INST CANCER IMMUNOLOGY INC
优先权: 2002
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈